Clinical News

View All >>

Predominantly Persistent IRF in nAMD Eyes Linked to Worse Long-Term Visual Acuity

1 hour ago

By Connor Iapoce

PP-IRF through year 2 was independently associated with worse long-term visual acuity and scar development.

Mean Changes in Visual Acuity Linked to Anti-VEGF Treatment Intensity

2 hours ago

By Connor Iapoce

Patients with nAMD, DME, BRVO-ME, and CRVO-ME showed limited visual acuity outcomes in clinical practice.

Higher Mortality Rate for NAFLD Patients With Fatigue

3 hours ago

By Kenny Walter

NAFLD resulted in a number of other negative outcomes, including sleep disturbance, cardiovascular disease, significant hepatic fibrosis, and advanced hepatic fibrosis.

High-Flow Oxygen Fails to Reduce Mortality due to COVID-19 Respiratory Failure

4 hours ago

By Giuliana Grossi

Conflicting evidence on the risks associated with intubation in patients with COVID-19 initiated a debate in the medical community regarding the benefit of utilizing high-flow oxygen.

Patrick S. Walsh, MD: Pediatric Influenza Patients and Treatment With Oseltamivir

5 hours ago

By Tim Smith

A discussion was held regarding research on the use of antivirals on younger influenza patients.

Maui Derm Tyk2 Psoriasis Archived Webcast

ACC ICI-Associated Myocarditis Archived Webcast

Provider and Caregiver Connection Live: Aligning Oncology and Cardiology Care to Identify and Manage ICI-Related Myocarditis

Crisis Point: The Physician Burnout Crisis

A 3-part series on the manifestations of physician burnout, how COVID-19 changed its scope and revealed systemic fractures, and finally, the path towards resolution and reformation.

Conference Coverage

View All >>

Novel Pain Therapy Addresses the Complex Pathway of Painful Diabetic Neuropathy

10 hours ago

By Giuliana Grossi

Dr. Craig Granowitz of Lexicon Pharmaceuticals details the success of the LX9211 clinical trial for painful diabetic neuropathy and the unique study design.

Patients With Vitiligo Report Varied Severe Symptoms Based on Skin Tone

September 08, 2022

By Tim Smith

Large numbers of vitiligo patients around the world have reported differing outcomes, with darker skin types expressing the more significant severity, according to new findings.

Ruxolitinib Beneficial Across Demographics of Patients with Vitiligo

September 08, 2022

By Tim Smith

Research presented at EADV 2022 sees positive outcomes with the targeted therapy for patients of varied backgrounds with vitiligo.

Promising Data from InPedILD Phase 3 Trial Revealed at ERS Congress 2022

September 08, 2022

By Giuliana Grossi

Novel insights into the risk-benefit profile of nintedanib in children and adolescents with fibrosing interstitial lung disease (ILD) were provided by late-breaking data presented at ERS 2022 regarding the InPedILD clinical trial.

Video Series

View All >>

Current FDA Approved JAK Inhibitors Use in Dermatological Care

Introduction to Janus Kinase (JAK) Inhibitors in Dermatology Care

The Importance of Patient Education in Atopic Dermatitis Management

Emerging Therapies and Future Directions for Pediatric Atopic Dermatitis

Patient Conversations Regarding RBC Health

Clinician Awareness of RBC Health and Related Laboratory Measurements

Monitoring Patients with C. difficile Infection (CDI) and rCDI

Fecal Microbiota Transplantation (FMT) for Treatment of C. difficile Infection (CDI)

Evolution of Pediatric Atopic Dermatitis Treatment Landscape

Considerations and Challenges With Topical Therapies for Pediatric Patients With Atopic Dermatitis